K Number
K130170
Device Name
EXSPIRON 1XI
Date Cleared
2013-05-29

(125 days)

Product Code
Regulation Number
868.1850
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
ExSpiron 1xi is indicated for use by healthcare professionals in healthcare facilities, such as post-operative care and critical care units, to monitor breathing in adult (at least 21 years old) patients. ExSpiron 1xi is a non-invasive system that graphically displays lung volume against time and reports an approximate value of: Tidal volume, Respiratory rate, and Minute ventilation ExSpiron 1xi measurements are used as an adjunct to other clinical information sources.
Device Description
The ExSpiron 1xi system consists of: Bioimpedance measurement system: A stabilized high frequency current generator is connected to two outer electrodes. The inner four electrodes are connected to an adaptive circuit that conditions the resulting voltage signal and converts it to digital form. Firmware performs signal acquisition and relays data to the panel PC. Computer: A Windows 7 PC performs signal processing and calibration, and runs the graphical user interface (GUI). The PC takes user input from a touch screen. The GUI is used for recording patient data and displaying the respiratory trace as well as scalar values and trends for minute volume, tidal volume, and respiratory rate. Single Patient Use ExSpiron™ 1xi Electrode PadSet: An electrode assembly containing six electrodes to be placed on the torso. It delivers current and records impedance measurements. The electrode PadSet is also used to perform subsystem checks prior to patient measurements.
More Information

Not Found

No
The description focuses on bioimpedance measurement, signal processing, and a standard graphical user interface. There is no mention of AI, ML, or related concepts like training/test sets for algorithms. The software is described as performing signal processing and calibration, which are typical functions for this type of device and do not inherently imply AI/ML.

No.
The device is indicated for monitoring breathing and displaying physiological measurements, which are diagnostic or monitoring functions, not therapeutic interventions.

Yes
The device monitors breathing and provides measurements like tidal volume, respiratory rate, and minute ventilation, which are used as an "adjunct to other clinical information sources" for assessing a patient's condition. While it doesn't offer a diagnosis itself, the information it provides supports diagnostic processes by healthcare professionals.

No

The device description explicitly lists hardware components including a bioimpedance measurement system, a computer (Windows 7 PC with touch screen), and a single-patient use electrode padset.

Based on the provided information, the ExSpiron 1xi is not an IVD (In Vitro Diagnostic) device.

Here's why:

  • Intended Use: The intended use clearly states that the device is used to "monitor breathing in adult... patients." This involves measuring physiological parameters directly from the patient's body (bioimpedance).
  • Device Description: The description details a system that uses electrodes placed on the torso to measure bioimpedance, which is then processed to derive respiratory parameters. This is a non-invasive, in-vivo measurement.
  • Lack of In Vitro Activity: There is no mention of the device being used to examine specimens (like blood, urine, tissue) outside of the body. IVD devices are specifically designed for testing such specimens.

Therefore, the ExSpiron 1xi is a medical device used for in-vivo physiological monitoring, not an in-vitro diagnostic device.

N/A

Intended Use / Indications for Use

ExSpiron 1xi is indicated for use by healthcare professionals in healthcare facilities, such as postoperative care and critical care units, to monitor breathing in adult (at least 21 years of age) patients.

ExSpiron 1xi is a non-invasive system that graphically displays lung volume against time and reports an approximate value of:

  • Tidal volume
  • Respiratory rate, and
  • Minute ventilation

ExSpiron 1xi measurements are used as an adjunct to other clinical information sources.

Product codes (comma separated list FDA assigned to the subject device)

BZK, BZQ

Device Description

The ExSpiron 1xi system consists of:
Bioimpedance measurement system: A stabilized high frequency current generator is connected to two outer electrodes. The inner four electrodes are connected to an adaptive circuit that conditions the resulting voltage signal and converts it to digital form. Firmware performs signal acquisition and relays data to the panel PC.
Computer: A Windows 7 PC performs signal processing and calibration, and runs the graphical user interface (GUI). The PC takes user input from a touch screen. The GUI is used for recording patient data and displaying the respiratory trace as well as scalar values and trends for minute volume, tidal volume, and respiratory rate.
Single Patient Use ExSpiron™ 1xi Electrode PadSet: An electrode assembly containing six electrodes to be placed on the torso. It delivers current and records impedance measurements. The electrode PadSet is also used to perform subsystem checks prior to patient measurements.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

torso

Indicated Patient Age Range

adult (at least 21 years old) patients.

Intended User / Care Setting

healthcare professionals in healthcare facilities, such as post-operative care and critical care units

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Nonclinical performance testing addressed specific modifications to the Monitor, Patient Cable, and Electrode PadSet as follows:
Software Verification & Validation
Safety Testing - IEC 60601-1 2nd Edition
Electromagnetic Compatibility - IEC 60601-1-2
ExSpiron 1Xi System Test Plan
Patient Cable Design Verification - Included testing to all the relevant sections of AAMI / ANSI EC53:1995/(R) 2008, ECG Cables and Leadwires
Electrode PadSet Design Verification - Included testing to all the relevant section of AAMI / ANSI EC12:2000/(R)2010, Disposable ECG Electrodes & AAMI / ANSI EC53:1995/(R) 2008, ECG Cables and Leadwires
Electrode - Biocompatibilty - ANSI/AAMI/ISO 10993-1 (Skin, prolonged duration)
All performance testing conducted on modifications to the Monitor, Patient Cable, and Electrode Padset were completed with successful results. Performance testing raised no new safety or efficacy concerns and demonstrated substantial equivalence to the predicate device.

No clinical testing was performed for this 510(k). The measurement algorithm and software are unchanged from the predicate. Measurement performance statistics were determined by clinical trials reported in the predicate 510(k), K120087.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

K120087

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 868.1850 Monitoring spirometer.

(a)
Identification. A monitoring spirometer is a device used to measure continuously a patient's tidal volume (volume of gas inhaled by the patient during each respiration cycle) or minute volume (the tidal volume multiplied by the rate of respiration for 1 minute) for the evaluation of the patient's ventilatory status.(b)
Classification. Class II (performance standards).

0

K130170

510(k) Summary ..

MAY 2 9 2013

: : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : :

í

510(k) OwnerRespiratory Motion, Inc.
Address305 Second Avenue, Suite B
Waltham, Massachusetts 02451
Phone781-373-1636
Fax781-373-1653
Contact personJenny Freeman, MD
Date 510(k)January 13, 2013
Summary
prepared
Trade nameExSpiron™ 1xi
Common nameRespiratory Monitor
ClassificationsMonitoring spirometer
Product code: BZK
Regulation: 21 CFR 868.1850
Breathing frequency monitor
Product code BZQ
Regulation: 21 CFR 868.2375
PredicateExSpiron Respiratory Monitor, cleared in 510(k) K120087.
devices
DeviceThe ExSpiron 1xi system consists of:
DescriptionBioimpedance measurement system: A stabilized high frequency current
generator is connected to two outer electrodes. The inner four electrodes are
connected to an adaptive circuit that conditions the resulting voltage signal
and converts it to digital form. Firmware performs signal acquisition and
relays data to the panel PC.
Computer: A Windows 7 PC performs signal processing and calibration,
and runs the graphical user interface (GUI). The PC takes user input from a
touch screen. The GUI is used for recording patient data and displaying the
respiratory trace as well as scalar values and trends for minute volume, tidal
volume, and respiratory rate.
Single Patient Use ExSpiron™ 1xi Electrode PadSet: An electrode
assembly containing six electrodes to be placed on the torso. It delivers
current and records impedance measurements. The electrode PadSet is also
used to perform subsystem checks prior to patient measurements.
Intended useExSpiron 1xi is indicated for use by healthcare professionals in healthcare facilities,
such as post-operative care and critical care units, to monitor breathing in adult (at
least 21 years old) patients.
ExSpiron 1xi is a non-invasive system that graphically displays lung volume against
time and reports an approximate value of:
Tidal volume,
Respiratory rate, and
Minute ventilation
ExSpiron 1xi measurements are used as an adjunct to other clinical information
sources.

·

.

:

.

.

·

1

Comparison ofCharacteristicExSpiron 1xiExSpironComment
technologicalIntended UseSee aboveSameThe Indications for Use are not
characteristicschanged in this Special 510(k).
TechnologyMeasurementSameThe fundamental technology is
is by thoracicnot changed
bioimpedance.
VolumeTidal volumeSameNo change
Measurements
Minute
volume
Volume vs.
time chart
RateRespiratorySameNo change
Measurementsrate
(breaths/min)
SafetyIEC 60601-1,SameNo change
second edition
NonclinicalPerformance testing addressed specific modifications to the Monitor, Patient Cable,
performanceand Electrode PadSet as follows:
testing:Software Verification & Validation
Safety Testing - IEC 60601-1 2nd Edition
Electromagnetic Compatibility - IEC 60601-1-2
ExSpiron 1Xi System Test Plan
Patient Cable Design Verification - Included testing to all the relevant
sections of AAMI / ANSI EC53:1995/(R) 2008, ECG Cables and Leadwires
Electrode PadSet Design Verification - Included testing to all the relevant
section of AAMI / ANSI EC12:2000/(R)2010, Disposable ECG Electrodes
& AAMI / ANSI EC53:1995/(R) 2008, ECG Cables and Leadwires
Electrode - Biocompatibilty - ANSI/AAMI/ISO 10993-1 (Skin, prolonged
duration)
All performance testing conducted on modifications to the Monitor, Patient
Cable, and Electrode Padset were completed with successful
results. Performance testing raised no new safety or efficacy concerns and
demonstrated substantial equivalence to the predicate device.
ClinicalNo clinical testing was performed for this 510(k). The measurement algorithm and
performancesoftware are unchanged from the predicate. Measurement performance statistics
testing:were determined by clinical trials reported in the predicate 510(k), K120087.
ConclusionsBased on the comparisons of intended use and on the results of testing, the ExSpiron
I xi is substantially equivalent in intended use, safety, and effectiveness to the
regarding safetyExSpiron respiratory monitor.
and
effectiveness:

: . .

.

:

100000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000

. .

:

2

DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/2/Picture/1 description: The image shows the logo for the Department of Health & Human Services (HHS). The logo consists of a stylized caduceus, which is a symbol often associated with healthcare. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular fashion around the caduceus.

Public Health Service

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

May 29, 2013

Jenny Freeman, M.D. President Respiratory Motion 305 Second Avenue, Suite B WALTHAM, M.A., 02451

Re: K130170

Trade/Device Name: ExSpiron™ 1xi Regulation Number: 21 CFR 868.1850 Regulation Name: Monitoring Spirometer Regulatory Class: II Product Code: BZK, BZQ Dated: April 26, 2013 Received: April 29, 2013

Dear Ms. Freeman:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

3

Page 2 - Ms. Freeman

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807): labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part

807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours.

Kwame O. Ulmer -S for

Anthony D. Watson, B.S., M.S., M.B.A. Director

Division of Anesthesiology, General Hospital, Respiratory, Infection Control and

Dental Devices

Office of Device Evaluation

Center for Devices and Radiological Health

Enclosure

4

Indications For Use

510(k) Number (if known): K 130170 Device Name: ExSpiron 1xi Indications for Use:

ExSpiron 1xi is indicated for use by healthcare professionals in healthcare facilities, such as postoperative care and critical care units, to monitor breathing in adult (at least 21 years of age) patients.

ExSpiron 1xi is a non-invasive system that graphically displays lung volume against time and reports an approximate value of:

  • Tidal volume, .
  • . Respiratory rate, and
  • Minute ventilation. *

ExSpiron 1xi measurements are used as an adjunct to other clinical information sources.

Lester Wª 2013.05 29 10

(Division Sign-Off) Division of Anesthesiology, General Hospital Intection Control, Dental Devices

K130170 510 (k) Number:

Prescription Use × (Part 21 CFR 801 Subpart D) AND/OR

Over-The-Counter Use (Part 21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)